Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

SRx Health Solutions (SRXH) Equity Average (2016 - 2025)

SRx Health Solutions' Equity Average history spans 15 years, with the latest figure at -$22.7 million for Q3 2025.

  • For Q3 2025, Equity Average rose 40.79% year-over-year to -$22.7 million; the TTM value through Sep 2025 reached -$22.7 million, up 40.79%, while the annual FY2025 figure was -$31.6 million, N/A changed from the prior year.
  • Equity Average reached -$22.7 million in Q3 2025 per SRXH's latest filing, down from -$19.0 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $60.3 million in Q4 2021 to a low of -$59.4 million in Q4 2024.
  • Average Equity Average over 5 years is $4.6 million, with a median of -$8.8 million recorded in 2023.
  • Peak YoY movement for Equity Average: surged 667.77% in 2022, then plummeted 1478.91% in 2025.
  • A 5-year view of Equity Average shows it stood at $60.3 million in 2021, then tumbled by 44.53% to $33.5 million in 2022, then crashed by 146.09% to -$15.4 million in 2023, then plummeted by 285.25% to -$59.4 million in 2024, then soared by 61.72% to -$22.7 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Equity Average are -$22.7 million (Q3 2025), -$19.0 million (Q2 2025), and -$27.9 million (Q1 2025).